Clinical Trial Update: SB-743921 In Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 study of SB-743921 in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SB-743921 (SB-743921)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Solid Tumor Cancer | Phase 1 | Status: COMPLETED